Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07910279

Curcumin Nano Patch and Autonomic Function in Shift-Working Healthcare Professionals

Conditions: Occupational Stress, Sleep Quality

Sex: All
Ages: 20 Years – 60 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 51
Sponsor: Taipei Medical University Shuang Ho Hospital

Location: Taipei Medical University Shuang Ho Hospital New Taipei City

Summary

This randomized, open-label, placebo-controlled crossover study compares a curcumin-containing patch with a cooling placebo patch without curcumin in healthcare professionals who work rotating shifts. It evaluates heart rate variability, stress, sleep quality, anxiety and depressive symptoms, and examines the relationships between wearable measurements and questionnaire scores. Participants are healthcare professionals aged 20 to 60 years at Taipei Medical University Shuang Ho Hospital in Taiwan. Each participant receives both patches in randomly assigned order. Each patch is used for at least 14 days, for 8 hours per day, with a washout of at least 14 days between periods. Participants and researchers know which patch is used. Wearable measurements are compared within the same participant across the two patch periods. Questionnaires are completed at the beginning and end of each period.

Eligibility Criteria

Inclusion Criteria: * Adults aged 20 to 60 years, of any sex, with full capacity to provide informed consent. * Current clinical healthcare professionals working in relevant units at Shuang Ho Hospital who perform shift work, including evening or night shifts, and are exposed to sustained occupational stress. * In generally good physical and mental health, without severe acute illness, and able to wear physiological monitoring equipment and follow study procedures. * Willing to use the HRV monitoring device and study patches, complete questionnaires and diaries, and provide written informed consent. Exclusion Criteria: * Current or previous major psychiatric illness, such as severe depression, bipolar disorder or schizophrenia, or current treatment with antidepressants, anxiolytics or other psychiatric medications that may affect autonomic function or interfere with study assessments. * Known clinically significant arrhythmia, including atrial fibrillation or atrioventricular block; an implanted cardiac pacemaker; or severe cardiovascular disease, including uncontrolled hypertension or heart failure. * Frequent or long-term use of hypnotics or sedatives, including benzodiazepines or Z-drugs, or other medications that may substantially affect sleep or HRV, such as beta blockers. * Known allergy to adhesive materials, turmeric, plants in the ginger family or related patch ingredients; or severe eczema, wounds or other skin conditions that make patch application unsuitable. * Pregnancy or breastfeeding. Participants who become pregnant during the study discontinue further participation. * Other conditions judged by the research team to make participation unsuitable, including inability to complete study procedures, anticipated prolonged leave or departure from shift work, or plans for major changes in daily routines within the two weeks before study initiation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07910279). StuddyBuddy aggregates publicly available trial information.